Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
No Difference in Effectiveness of 8 vs 12 Weeks of Ledipasvir and Sofosbuvir for Treatment of Hepatitis C in Black Patients.
Marcus JL, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Lam JO, Pauly MP, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ. Marcus JL, et al. Among authors: witt dj. Clin Gastroenterol Hepatol. 2018 Jun;16(6):927-935. doi: 10.1016/j.cgh.2018.03.003. Epub 2018 Mar 11. Clin Gastroenterol Hepatol. 2018. PMID: 29535057 Free PMC article.
Disparities in Initiation of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection in an Insured Population.
Marcus JL, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Lam JO, Pauly MP, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ. Marcus JL, et al. Among authors: witt dj. Public Health Rep. 2018 Jul/Aug;133(4):452-460. doi: 10.1177/0033354918772059. Epub 2018 May 11. Public Health Rep. 2018. PMID: 29750893 Free PMC article.
Hepatitis C treatment uptake and response among human immunodeficiency virus/hepatitis C virus-coinfected patients in a large integrated healthcare system.
Lam JO, Hurley LB, Chamberland S, Champsi JH, Gittleman LC, Korn DG, Lai JB, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ, Marcus JL. Lam JO, et al. Among authors: witt dj. Int J STD AIDS. 2019 Jun;30(7):689-695. doi: 10.1177/0956462419836520. Epub 2019 May 2. Int J STD AIDS. 2019. PMID: 31046611 Free PMC article.
Life Expectancy of Insured People With and Without Hepatitis C Virus Infection, 2007-2017.
Marcus JL, Hurley LB, Chamberland S, Champsi JH, Korn DG, Lai JB, Lam JO, Quesenberry CP Jr, Ready J, Saxena V, Seo SI, Witt DJ, Silverberg MJ. Marcus JL, et al. Among authors: witt dj. Open Forum Infect Dis. 2020 Feb 5;7(2):ofaa044. doi: 10.1093/ofid/ofaa044. eCollection 2020 Feb. Open Forum Infect Dis. 2020. PMID: 32128339 Free PMC article.
Boceprevir for untreated chronic HCV genotype 1 infection.
Poordad F, McCone J Jr, Bacon BR, Bruno S, Manns MP, Sulkowski MS, Jacobson IM, Reddy KR, Goodman ZD, Boparai N, DiNubile MJ, Sniukiene V, Brass CA, Albrecht JK, Bronowicki JP; SPRINT-2 Investigators. Poordad F, et al. N Engl J Med. 2011 Mar 31;364(13):1195-206. doi: 10.1056/NEJMoa1010494. N Engl J Med. 2011. PMID: 21449783 Free PMC article. Clinical Trial.
Effects of ribavirin dose reduction vs erythropoietin for boceprevir-related anemia in patients with chronic hepatitis C virus genotype 1 infection--a randomized trial.
Poordad F, Lawitz E, Reddy KR, Afdhal NH, Hézode C, Zeuzem S, Lee SS, Calleja JL, Brown RS Jr, Craxi A, Wedemeyer H, Nyberg L, Nelson DR, Rossaro L, Balart L, Morgan TR, Bacon BR, Flamm SL, Kowdley KV, Deng W, Koury KJ, Pedicone LD, Dutko FJ, Burroughs MH, Alves K, Wahl J, Brass CA, Albrecht JK, Sulkowski MS; Protocol 6086 Investigators. Poordad F, et al. Gastroenterology. 2013 Nov;145(5):1035-1044.e5. doi: 10.1053/j.gastro.2013.07.051. Epub 2013 Aug 4. Gastroenterology. 2013. PMID: 23924660 Clinical Trial.
Anemia during treatment with peginterferon Alfa-2b/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial.
Sulkowski MS, Poordad F, Manns MP, Bronowicki JP, Rajender Reddy K, Harrison SA, Afdhal NH, Sings HL, Pedicone LD, Koury KJ, Sniukiene V, Burroughs MH, Albrecht JK, Brass CA, Jacobson IM; SPRINT-2 Trial Investigators. Sulkowski MS, et al. Hepatology. 2013 Mar;57(3):974-84. doi: 10.1002/hep.26096. Epub 2013 Feb 11. Hepatology. 2013. PMID: 23081753 Clinical Trial.
43 results